“Impact of GLP-1 Receptor Agonists on Cardiovascular Risk Reduction in Patients With Type 2 Diabetes”. Journal of Carcinogenesis 24, no. 10s (November 2, 2025): 141–153. Accessed December 6, 2025. https://carcinogenesis.com/index.php/JOC/article/view/1530.